In 2018, digital healthcare is not only a key topic, it’s being talked about and promoted as a lynchpin for effective communication, engagement and outcomes.

Investor’s Business Daily looked at three small biotech companies that appear to be leading the CRISPR race.

Some analysts have picked “winners and losers” from the 2018 J.P. Morgan Healthcare Conference. CNBC’s Jim Cramer made his picks related to stock performance.

In terms of acquisitions, the company is looking to expand its immunology pipeline as well as oncology.

The J.P. Morgan Healthcare Conference is a yearly opportunity for the biopharma industry to make major announcements and allow analysts, investors and the media pick the brains of top execs. Here is a look at what four of the top big biopharma companies shared at the meeting.

bluebird bio announced that it expected to file three applications for regulatory approval by the end of 2019.

Vertex Pharmaceuticals reportedly terminated a long-acting trial combining a recently acquired therapy with the company’s cystic fibrosis drug Kalydeco.

Scheduled for September 23, 2016 in Washington, DC, USA   Princeton, NJ—August 15, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced that it is holding a Stakeholder Conference for its Initiative on US Value Assessment Frameworks on September 23 in Washington, DC, USA.  ISPOR’s Initiative on US Value Assessment Frameworks was created to inform […]

The speakers agreed: It’s prime time for the next generation of industry leaders to step up, speak up and be counted in Washington to ensure that policy makers fully understand the value of robust communication to the delivery of efficient and effective healthcare in America. The message came together on May 11 in Washington when a Congressman, inside-the-beltway experts, and key industry CEOs convened with more than 60 up-and-coming stars from the health agency networks, independent agencies, medical publishers, and digital content providers to review medical policy issues at the Coalition for Healthcare Communication’s Rising Leaders Conference.